5,811 Shares in DaVita Inc. (NYSE:DVA) Purchased by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd purchased a new position in DaVita Inc. (NYSE:DVA) during the 4th quarter, Holdings Channel reports. The fund purchased 5,811 shares of the company’s stock, valued at approximately $868,000.

Other institutional investors also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC purchased a new position in DaVita in the 3rd quarter worth about $25,000. Blue Trust Inc. grew its holdings in DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares in the last quarter. Quarry LP bought a new position in DaVita during the 3rd quarter worth about $60,000. Versant Capital Management Inc grew its holdings in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares in the last quarter. Finally, ORG Wealth Partners LLC bought a new position in DaVita during the 3rd quarter worth about $97,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Barclays increased their target price on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $161.80.

DaVita Stock Down 0.2 %

NYSE:DVA opened at $176.16 on Monday. The stock has a market capitalization of $14.44 billion, a P/E ratio of 19.00, a P/E/G ratio of 0.85 and a beta of 0.92. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The company’s 50-day simple moving average is $159.72 and its 200-day simple moving average is $155.28. DaVita Inc. has a fifty-two week low of $107.74 and a fifty-two week high of $179.60.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.